Semiconductor Embedded Socks for Ankle Sprains
Launched by UNIVERSITY OF COLORADO, DENVER · Jun 9, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether special socks made with semiconductor fabric can help people heal better after an ankle sprain. Researchers want to see if these socks improve recovery compared to regular compression socks by looking at symptoms like pain and how well the ankle works during the healing process. Participants will wear the socks throughout their recovery and keep track of how their ankle feels and functions over time.
People who might be eligible to join are adults between 18 and 69 years old who have recently injured their ankle, including sprains or certain types of fractures, and have had pain for at least one day. However, those with certain health conditions like nerve problems, recent surgery on their leg, chronic pain, infections, or recent tobacco use won’t be able to participate. If you join, you’ll be asked to wear the assigned socks during your recovery and regularly share updates about your symptoms and how well you can use your ankle. This study is currently looking for volunteers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ankle sprain, avulsion fracture, distal fibular fracture
- • Pain for at least 1 day
- • Patients 18-69 years old
- Exclusion Criteria:
- • Patients with neurological conditions
- • Patients with prior surgical treatment of lower limb injury
- • Patients with chronic pain conditions
- • Patient with auto-immune or auto-inflammatory disease
- • Patients with tobacco use in last 90 days
- • Patients with history of metabolic disorders
- • Patients with open wound at area of application
- • Patients with acute or systemic infection
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Nicholas Alfonso, MD
Principal Investigator
University of Colorado Department of Orthopedics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported